BACKGROUND & AIMS: Germline variations in allele-specific expression (ASE) are associated with highly penetrant familial cancers, but their role in common sporadic cancers is unclear. ASE of adenomatous polyposis coli (APC) is associated with pathogenesis of familial adenomatous polyposis. We investigated whether moderate variations in ASE of APC contribute to common forms of colorectal cancer (CRC). METHODS: Denaturing high-performance liquid chromatography was used to analyze germline ASE of APC in blood samples from patients with CRC (cases, n = 53) and controls (n = 68). Means, medians, and variances of ASE were compared. Variants in the APC gene region also were analyzed. RESULTS: The distribution of ASE differed significantly between groups; cases had significantly larger amounts of variance than controls (P = .0004). Risk for CRC increased proportionally with the degree of deviation from the mean. The odds ratio for individuals with levels of ASE that deviated more than 1 standard deviation from the mean was 3.97 (95% confidence interval, 1.71-9.24; P = .001); for those with levels greater than 1.645 standard deviations, the odds ratio was 13.46 (95% confidence interval, 1.76-609.40; P = .005). Sequence analysis revealed that a patient with a high level of ASE who did not have a family history of CRC carried a nonsense mutation in APC (p.Arg216X). Genotype analysis of APC associated multiple single-nucleotide polymorphisms with ASE values and/or variance among cases, but not controls. Cis variants, therefore, might account for some of the variance in ASE of APC. CONCLUSIONS: Patients with CRC have a larger variance in germline levels of ASE in APC than controls; large distances from the mean ASE were associated with risk for common forms of CRC.
BACKGROUND & AIMS: Germline variations in allele-specific expression (ASE) are associated with highly penetrant familial cancers, but their role in common sporadic cancers is unclear. ASE of adenomatous polyposis coli (APC) is associated with pathogenesis of familial adenomatous polyposis. We investigated whether moderate variations in ASE of APC contribute to common forms of colorectal cancer (CRC). METHODS: Denaturing high-performance liquid chromatography was used to analyze germline ASE of APC in blood samples from patients with CRC (cases, n = 53) and controls (n = 68). Means, medians, and variances of ASE were compared. Variants in the APC gene region also were analyzed. RESULTS: The distribution of ASE differed significantly between groups; cases had significantly larger amounts of variance than controls (P = .0004). Risk for CRC increased proportionally with the degree of deviation from the mean. The odds ratio for individuals with levels of ASE that deviated more than 1 standard deviation from the mean was 3.97 (95% confidence interval, 1.71-9.24; P = .001); for those with levels greater than 1.645 standard deviations, the odds ratio was 13.46 (95% confidence interval, 1.76-609.40; P = .005). Sequence analysis revealed that a patient with a high level of ASE who did not have a family history of CRC carried a nonsense mutation in APC (p.Arg216X). Genotype analysis of APC associated multiple single-nucleotide polymorphisms with ASE values and/or variance among cases, but not controls. Cis variants, therefore, might account for some of the variance in ASE of APC. CONCLUSIONS:Patients with CRC have a larger variance in germline levels of ASE in APC than controls; large distances from the mean ASE were associated with risk for common forms of CRC.
Authors: Gitana Aceto; Maria Cristina Curia; Serena Veschi; Laura De Lellis; Sandra Mammarella; Teresa Catalano; Liborio Stuppia; Giandomenico Palka; Rosa Valanzano; Francesco Tonelli; Vincenzo Casale; Vittoria Stigliano; Francesco Cetta; Pasquale Battista; Renato Mariani-Costantini; Alessandro Cama Journal: Hum Mutat Date: 2005-10 Impact factor: 4.878
Authors: I M Frayling; N E Beck; M Ilyas; I Dove-Edwin; P Goodman; K Pack; J A Bell; C B Williams; S V Hodgson; H J Thomas; I C Talbot; W F Bodmer; I P Tomlinson Journal: Proc Natl Acad Sci U S A Date: 1998-09-01 Impact factor: 11.205
Authors: Valur Emilsson; Gudmar Thorleifsson; Bin Zhang; Amy S Leonardson; Florian Zink; Jun Zhu; Sonia Carlson; Agnar Helgason; G Bragi Walters; Steinunn Gunnarsdottir; Magali Mouy; Valgerdur Steinthorsdottir; Gudrun H Eiriksdottir; Gyda Bjornsdottir; Inga Reynisdottir; Daniel Gudbjartsson; Anna Helgadottir; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Unnur Styrkarsdottir; Solveig Gretarsdottir; Kristinn P Magnusson; Hreinn Stefansson; Ragnheidur Fossdal; Kristleifur Kristjansson; Hjortur G Gislason; Tryggvi Stefansson; Bjorn G Leifsson; Unnur Thorsteinsdottir; John R Lamb; Jeffrey R Gulcher; Marc L Reitman; Augustine Kong; Eric E Schadt; Kari Stefansson Journal: Nature Date: 2008-03-16 Impact factor: 49.962
Authors: Boris Pasche; Kari B Wisinski; Maureen Sadim; Virginia Kaklamani; Michael J Pennison; Qinghua Zeng; Naresh Bellam; Jacquelyn Zimmerman; Nengjun Yi; Kui Zhang; John Baron; Daniel O Stram; M Geoffrey Hayes Journal: J Exp Clin Cancer Res Date: 2010-05-25
Authors: Laura Valle; Tarsicio Serena-Acedo; Sandya Liyanarachchi; Heather Hampel; Ilene Comeras; Zhongyuan Li; Qinghua Zeng; Hong-Tao Zhang; Michael J Pennison; Maureen Sadim; Boris Pasche; Stephan M Tanner; Albert de la Chapelle Journal: Science Date: 2008-08-14 Impact factor: 47.728
Authors: Kishore Guda; Leanna Natale; James Lutterbaugh; Georgia L Wiesner; Susan Lewis; Stephan M Tanner; Jerneja Tomsic; Laura Valle; Albert de la Chapelle; Robert C Elston; Joseph Willis; Sanford D Markowitz Journal: Cancer Res Date: 2009-06-09 Impact factor: 12.701
Authors: Gitana Maria Aceto; Fabiana Fantini; Sabrina De Iure; Marta Di Nicola; Giandomenico Palka; Rosa Valanzano; Patrizia Di Gregorio; Vittoria Stigliano; Maurizio Genuardi; Pasquale Battista; Alessandro Cama; Maria Cristina Curia Journal: J Exp Clin Cancer Res Date: 2015-10-28
Authors: Laura De Lellis; Gitana Maria Aceto; Maria Cristina Curia; Teresa Catalano; Sandra Mammarella; Serena Veschi; Fabiana Fantini; Pasquale Battista; Vittoria Stigliano; Luca Messerini; Cristina Mareni; Paola Sala; Lucio Bertario; Paolo Radice; Alessandro Cama Journal: PLoS One Date: 2013-11-20 Impact factor: 3.240
Authors: M Loredana Marcovecchio; Rosalba Florio; Fabio Verginelli; Laura De Lellis; Cristian Capelli; Delfina Verzilli; Francesco Chiarelli; Angelika Mohn; Alessandro Cama Journal: PLoS One Date: 2016-05-05 Impact factor: 3.240
Authors: Taina T Nieminen; Walter Pavicic; Noora Porkka; Matti Kankainen; Heikki J Järvinen; Anna Lepistö; Päivi Peltomäki Journal: Oncotarget Date: 2016-10-25